Doctor Eva Blychert
AstraZeneca Pharmaceutical Technology & Development, Gothenburg (Sweden)
Pharmacokinetic profiles of orodispersible ticagrelor tablets in healthy Western and Japanese subjects.
Event: ESC Congress 2017
Topic: Thrombosis and platelets
Session: Acute coronary syndromes
ESC 365 is supported by
